Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Nuclear Medicine & Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2016-2027
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2016-2027
2.2 Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2021 Versus 2027
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2027)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2016-2021
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2022-2027)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2027)
2.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2016-2021
2.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
3 Global Nuclear Medicine & Radiopharmaceuticals by Manufacturers
3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2016-2021)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2016-2021)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Type
3.5.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.5.3 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 China Isotope & Radiation
4.1.1 China Isotope & Radiation Corporation Information
4.1.2 China Isotope & Radiation Description, Business Overview
4.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
4.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.1.5 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.1.6 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.1.7 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.1.8 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue by Sales Channel
4.1.9 China Isotope & Radiation Recent Development
4.2 Dongcheng
4.2.1 Dongcheng Corporation Information
4.2.2 Dongcheng Description, Business Overview
4.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
4.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.2.6 Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.2.7 Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.2.8 Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue by Sales Channel
4.2.9 Dongcheng Recent Development
4.3 Jaco
4.3.1 Jaco Corporation Information
4.3.2 Jaco Description, Business Overview
4.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Products Offered
4.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Jaco Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.3.6 Jaco Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.3.7 Jaco Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.3.8 Jaco Nuclear Medicine & Radiopharmaceuticals Revenue by Sales Channel
4.3.9 Jaco Recent Development
4.4 Ciaeriar
4.4.1 Ciaeriar Corporation Information
4.4.2 Ciaeriar Description, Business Overview
4.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Products Offered
4.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.4.6 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.4.7 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.4.8 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue by Sales Channel
4.4.9 Ciaeriar Recent Development
4.5 Advanced Molecular-imaging Solution
4.5.1 Advanced Molecular-imaging Solution Corporation Information
4.5.2 Advanced Molecular-imaging Solution Description, Business Overview
4.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Products Offered
4.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.5.6 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.5.7 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.5.8 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue by Sales Channel
4.5.9 Advanced Molecular-imaging Solution Recent Development
4.6 Shanghai Atom Kexing
4.6.1 Shanghai Atom Kexing Corporation Information
4.6.2 Shanghai Atom Kexing Description, Business Overview
4.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Products Offered
4.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.6.6 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue by Application
4.6.7 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Area
4.6.8 Shanghai Atom Kexing Recent Development
5 Breakdown Data by Type
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2027)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027)
5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2027)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2016-2027)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
5.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2027)
6.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021)
6.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027)
6.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2027)
6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2016-2027)
6.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021)
6.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
6.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
6.3 Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
7.2 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2027)
7.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2027)
7.3 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type
7.4 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2027)
8.2.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2027)
8.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type
8.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application
9 Europe
9.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
9.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2027)
9.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2027)
9.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type
9.4 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application
10 Latin America
10.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
10.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2027)
10.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2027)
10.3 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type
10.4 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2027)
11.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2027)
11.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type
11.4 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Nuclear Medicine & Radiopharmaceuticals Supply Chain Analysis
12.2 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
12.3 Nuclear Medicine & Radiopharmaceuticals Clients Analysis
12.4 Nuclear Medicine & Radiopharmaceuticals Sales Channel and Sales Model Analysis
12.4.1 Nuclear Medicine & Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Nuclear Medicine & Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Nuclear Medicine & Radiopharmaceuticals Distributors
13 Market Dynamics
13.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers
13.2 Nuclear Medicine & Radiopharmaceuticals Market Opportunities
13.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
13.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Diagnostic
Table 3. Major Manufacturers of Therapeutic
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2021 VS 2027
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2016-2021) & (K Units)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer (2016-2021)
Table 12. Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 13. Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturer (2016-2021)
Table 14. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2016-2021) & (US$/Unit)
Table 15. Ranking of Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2020
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2020)
Table 18. Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. China Isotope & Radiation Corporation Information
Table 23. China Isotope & Radiation Description and Business Overview
Table 24. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 25. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
Table 26. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 27. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 28. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 29. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 30. China Isotope & Radiation Recent Development
Table 31. Dongcheng Corporation Information
Table 32. Dongcheng Description and Business Overview
Table 33. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 34. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product
Table 35. Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 36. Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 37. Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Dongcheng Recent Development
Table 40. Jaco Corporation Information
Table 41. Jaco Description and Business Overview
Table 42. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 43. Jaco Nuclear Medicine & Radiopharmaceuticals Product
Table 44. Jaco Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 45. Jaco Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 46. Jaco Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Jaco Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Jaco Recent Development
Table 49. Ciaeriar Corporation Information
Table 50. Ciaeriar Description and Business Overview
Table 51. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 52. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product
Table 53. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 54. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 55. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Ciaeriar Recent Development
Table 58. Advanced Molecular-imaging Solution Corporation Information
Table 59. Advanced Molecular-imaging Solution Description and Business Overview
Table 60. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product
Table 62. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 63. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 64. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Advanced Molecular-imaging Solution Recent Development
Table 67. Shanghai Atom Kexing Corporation Information
Table 68. Shanghai Atom Kexing Description and Business Overview
Table 69. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 70. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product
Table 71. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 72. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 73. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Shanghai Atom Kexing Recent Development
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 76. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 77. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 78. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 79. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 80. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 81. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 82. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 83. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 84. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 85. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 86. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 87. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 88. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 89. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 90. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2022-2027) & (K Units)
Table 91. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2027) & (US$ Million)
Table 92. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 93. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 94. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 95. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 96. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 97. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 98. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 99. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 100. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 101. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 102. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 103. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 104. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 105. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 106. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 107. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 108. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2022-2027) & (K Units)
Table 109. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 110. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021) & (K Units)
Table 112. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021) & (K Units)
Table 113. Nuclear Medicine & Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 114. Nuclear Medicine & Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 115. Nuclear Medicine & Radiopharmaceuticals Clients Status and Trend
Table 116. Nuclear Medicine & Radiopharmaceuticals Typical Clients
Table 117. Nuclear Medicine & Radiopharmaceuticals Distributors
Table 118. Key Drivers: Impact Analysis (2022-2027)
Table 119. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Table 120. Nuclear Medicine & Radiopharmaceuticals Market Opportunities
Table 121. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 122. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Table 123. Nuclear Medicine & Radiopharmaceuticals Porter's Five Forces Analysis
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. Diagnostic Product Picture
Figure 4. Therapeutic Product Picture
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 6. Oncology Examples
Figure 7. Thyroid Examples
Figure 8. Cardiology Examples
Figure 9. Others Examples
Figure 10. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2016-2027)
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturer in 2020
Figure 18. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2016-2027)
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2016-2027)
Figure 21. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2016-2027)
Figure 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2016-2027)
Figure 24. Nuclear Medicine & Radiopharmaceuticals Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 25. North America Nuclear Medicine & Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
Figure 26. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 27. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 28. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
Figure 29. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2027)
Figure 30. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 32. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2027)
Figure 35. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2027)
Figure 36. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 37. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 38. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 39. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2027)
Figure 40. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Figure 41. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 42. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 43. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2016-2027 (US$ Million)
Figure 44. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2027)
Figure 45. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2027)
Figure 46. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Figure 47. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 48. Nuclear Medicine & Radiopharmaceuticals Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Nuclear Medicine & Radiopharmaceuticals Raw Materials by Region in 2020
Figure 50. Nuclear Medicine & Radiopharmaceuticals Distribution Channels
Figure 51. Global Nuclear Medicine & Radiopharmaceuticals Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 52. Global Nuclear Medicine & Radiopharmaceuticals Percentage 2016-2027: Online Sales VS Offline Sales
Figure 53. Porter's Five Forces Analysis
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs